Chemical formula: C₁₂H₁₅N₃O₂S  Molecular mass: 265.331 g/mol  PubChem compound: 2082

Active ingredient description

Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
P02CA03 Albendazole P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 54965-21-8
DrugBank Drug: DB00518
KEGG Drug: D00134
PubChem Compound: 2082
RxNorm Ingredient: 430
SNOMED-CT Concept: 387558006
Albendazole (substance)
UNII Identifier: F4216019LN


Albendazole is an active ingredient of these brands:

United States (US)

Australia (AU)

Austria (AT)

Cyprus (CY)

Estonia (EE)

France (FR)

Israel (IL)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.